Loading organizations...
Loading organizations...
Develops advanced implantable Deep Brain Stimulation systems.
Aleva Neurotherapeutics has raised $73.2M across 6 funding rounds.
Aleva Neurotherapeutics has raised $73.2M in total across 6 funding rounds.
Aleva Neurotherapeutics has raised $73.2M in total across 6 funding rounds.
Aleva Neurotherapeutics's investors include Forrestal Capital, Anthony Borowicz, Banexi Ventures Partners, BB Biotech Ventures, BioMedPartners, Initiative Capital Romandie, Kinled Holding, Sophie PIERRIN LEPINARD, Juergen Eckhardt, Markus Hosang.
Aleva Neurotherapeutics has raised $73.2M across 6 funding rounds. Most recently, it raised $8.0M Series E in December 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 16, 2019 | $8.0M Series E | ||
| Oct 4, 2017 | $13.0M Series D | Forrestal Capital | |
| May 27, 2016 | $18.0M Series C | Anthony Borowicz | Banexi Ventures Partners, BB Biotech Ventures, BioMedPartners, Forrestal Capital, Initiative Capital Romandie, Kinled Holding |
| Sep 4, 2015 | $16.1M Other Equity | Banexi Ventures Partners, BB Biotech Ventures, BioMedPartners, Initiative Capital Romandie | |
| Apr 10, 2012 | $4.3M Series B | Sophie PIERRIN LEPINARD | BB Biotech Ventures, BioMedPartners, Initiative Capital Romandie |
| Aug 31, 2011 | $13.7M Series A | Juergen Eckhardt, Markus Hosang | Initiative Capital Romandie |